EcoDrugPlus

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 2

Ensembl ID : ENSOMYG00000002842
Gene Symbol: HSP90AA1.2
1 Cross references
340 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 2

Ensembl ID : ENSOMYG00000036907
Gene Symbol: HSP90AA1.2
1 Cross references
339 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSOMYG00000040017
Gene Symbol: HSP90AB1
2 Cross references
333 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSOMYG00000041318
Gene Symbol: HMGB1B
1 Cross references
503 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSOMYG00000001293
Gene Symbol: HRH1
1 Cross references
180 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOMYG00000066809
Gene Symbol: HDAC1
2 Cross references
248 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOMYG00000003917
Gene Symbol: HDAC1
1 Cross references
248 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSOMYG00000024303
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSOMYG00000006191
Gene Symbol: HDAC11
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSOMYG00000008291
Gene Symbol: HDAC2
1 Cross references
209 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSOMYG00000027815
Gene Symbol: HDAC4
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSOMYG00000016587
Gene Symbol: HDAC4
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).